Although lifestyle changes take longer than an infusion to deliver results, they build a foundation for lasting health and beauty
How We Make Tirzepatide Use Safe for Patients At TrimBody M.D, we make sure to focus on medication safety when patients share concerns about their vision or nerve-related symptoms
Metabolic syndrome with elevated liver enzymes : Patients presenting with multiple metabolic risk factors (central obesity, hypertension, dyslipidemia, impaired fasting glucose) and persistently elevated ALT/AST may benefit from the comprehensive metabolic improvements offered by GLP-1 therapy
Comparative safety data shows acute kidney injury was listed in 0.47% of tirzepatide adverse event reports versus 1.07% of semaglutide reports in the FDA Adverse Event Reporting System (FAERS), with the reporting odds ratio favoring tirzepatide
Similar findings have been observed Pan et al (2024), which noted significant differences between multiple GLP-1 medications compared with placebo for achieving greater than 5%, 10%, and even 15% weight loss
Wegovy (semaglutide): a new weight loss drug for chronic weight management